恒瑞医药(01276.HK)：”HRS-6257片“获药物临床试验批准

Core Viewpoint - Heng Rui Medicine has received approval from the National Medical Products Administration for the clinical trial of HRS-6257 tablets, which will be conducted soon [1]. Group 1: Drug Information - Drug Name: HRS-6257 tablets [2] - Dosage Form: Tablet [2] - Application Matter: Clinical trial [2] - Acceptance Numbers: CXHL2501046, CXHL2501047 [2] - Approval Conclusion: The clinical trial application for HRS-6257 tablets, submitted on September 26, 2025, meets the requirements for drug registration and is approved for clinical trials aimed at postoperative analgesia [2].